patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: The Company's is Solid.

Been watching the ID's raise up and down. my AI records and tracks individual Prices changes of the ask and bid. It is showing more Fluctuations around the price then at the price, more than usaual vs the volume, when graphed.

It would have been nice to have act, but I always break carmera lens.

Just 7thhvn to Angelwish

Share
New Message
Please login to post a reply